Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001...
Anika Therapeutics, Inc. began a recall of Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001 Distributed by: STAAR Surgical Inc., Monrovia CA on . The reason FDA records is "Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.
Recall record
- Recall number
- Z-1382-05
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Anika Therapeutics, Inc.
- Product
- Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001 Distributed by: STAAR Surgical Inc., Monrovia CA
- Product code
- LZP Aid, Surgical, Viscoelastic
- Reason for recall
- Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe.
- Root cause tag
- packaging
- FDA root cause
- Other
- Action
- Anika Therapeutics notified Distributor accounts by telephone on July 14. The letters were faxed and sent by Fedex on July 14. Distributors were provided with a end-user letter template letter for notification to their accounts.
- Quantity in commerce
- 20,549 units
- Distribution
- CA, NC
- Product codes and lots
- Lot Numbers: B041118C, B050510A
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
